Clinical Trial Update: MK-0524B Lipid Study (MK-0524B-063) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of MK-0524B for primary hypercholesterolemia and mixed dyslipidemia has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• MK-0524B

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2016-04-01